liver-cirrhosis

Documents about liver-cirrhosis

• North American Study for the Treatment of Refractory Ascites (NASTRA)#154819ClinicalTrials.gov
• Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial#165943ClinicalTrials.gov
• Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices#253101ClinicalTrials.gov
• Freiburg TIPS Registry#296589ClinicalTrials.gov
• Eosinophilic Esophagitis and Risk of Non-Alcoholic Fatty Liver Disease and Cirrhosis: A Multi-Center Retrospective Study.#409518NCBI PubMed Central
• Thoracoscopic Mesh Repair of Diaphragmatic Defects for Hepatic Hydrothorax#827616ClinicalTrials.gov
• Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome#837704ClinicalTrials.gov
• TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension#841260ClinicalTrials.gov
• Influence of Sarcopenia on the Course of the Diseases#870213ClinicalTrials.gov
• Autologous BMNC Infusion for Liver Cirrhosis in Children With BA#904130ClinicalTrials.gov
• Correlation between cystasin C to disease severity of cirrhosis on model of end stage liver disease score#930358Acta Interna: The Journal of Internal Medicine
• A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)#830592ClinicalTrials.gov
• Association of Statin Use with Reduced Primary Liver Cancer Risk, Independent of Age and Cirrhosis Protection in MASLD.#9152NCBI PubMed Central
• Impact of Donor Cirrhosis Outcome Risk Estimator (CORE) Score on Recipient Outcomes Following Living-donor Liver Transplantation.#150060NCBI PubMed Central
• Earlier liver cirrhosis onset in intrafamilial hepatitis Delta virus transmission in Moldova#288296HAL (France)
• Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents#806676ClinicalTrials.gov
• High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics#807474ClinicalTrials.gov
• Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function#841251ClinicalTrials.gov
• FibroScan ® Study: Assessing Liver Fibrosis in Patients Using Methotrexate for Psoriasis#869342ClinicalTrials.gov
• Austrian Registry on Transjugular Intrahepatic Portosystemic Shunts#914757ClinicalTrials.gov
• Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis#858767ClinicalTrials.gov
• The chinese herbal decoction danggui buxue tang inhibits angiogenesis in a rat model of liver fibrosis.#341982Apollo
• Establishment and Assessment of the HVPG Using Biofluid Mechanics (HVPGBFM)#158066ClinicalTrials.gov
• Rifamycin in Minimal Hepatic Encephalopathy#800690ClinicalTrials.gov
• Using Bedside Ultrasound to Understand Fluid Management in Patients With Chronic Liver Disease#865084ClinicalTrials.gov
• Comparison of Pre-operative EUS Guided and Intra-operative Direct Portal Vein Pressure Measurement in Pretransplant Cirrhotics#881075ClinicalTrials.gov
• Clinical Application of Simcyp-Guided Doses of Antihypertensive Drugs in Cirrhotic Patients#884773ClinicalTrials.gov
• Value of Von Willebrand Factor in Portal Hypertension#981059ClinicalTrials.gov
• Biliary Complications in Live Donor Liver Transplantation#1031344ClinicalTrials.gov
• Evaluating the Pharmacokinetics and Safety of Miricorilant#894418ClinicalTrials.gov
• A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy.#836853ClinicalTrials.gov
• The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding#373681ClinicalTrials.gov
• Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis#803586ClinicalTrials.gov
• Optimal Clinical Predictors to AKI in Cirrhotic Patients Experienced Acute Gastrointestinal Hemorrhage#869361ClinicalTrials.gov
• Rifaximin for the Secondary Prevention of Spontaneous Bacterial Peritonitis Recurrence in Cirrhotic Patients#884257ClinicalTrials.gov
• Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease#903184ClinicalTrials.gov
• Evaluation of Probiotics in the Treatment of Portal Hypertension#905168ClinicalTrials.gov
• Macrophage Activation Markers During Sofosbuvir-based Treatment Regimes of Chronic Hepatitis C#911504ClinicalTrials.gov
• ROLE OF URINARY BIOMARKER NEUTROPHIL GELATINASE ASSOCIATED LIPOCALCIN (NGAL) IN EARLY PREDICTION OF AKI IN CIRRHOSIS OF LIVER#913253ClinicalTrials.gov
• B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites#917162ClinicalTrials.gov
• A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)#343751ClinicalTrials.gov
• A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease#1007513ClinicalTrials.gov
• Exploring Patients’ Experiences of Living With Liver Cirrhosis-Related Ascites and Receiving Follow-Up Care in Nurse-Led Outpatient Clinics.#148060NCBI PubMed Central
• Machine learning-driven clinical decision support for liver cirrhosis: a gut microbiome-based web prediction model with explainable AI integration.#218906NCBI PubMed Central
• Association between the blood urea nitrogen to albumin ratio and all-cause mortality in critically ill patients with liver cirrhosis.#323247NCBI PubMed Central
• Clinical and Laboratory Factors Associated With In-Hospital Mortality Among Patients With Decompensated Liver Cirrhosis: A Retrospective Study From Indonesia.#354715NCBI PubMed Central
• Trends in the global burden of anemia associated with liver cirrhosis: an assessment from 1990 to 2021 and projections to 2045.#415547NCBI PubMed Central
• It takes two to tango: Preserving liver function competes with response to systemic therapy in patients with HCC and decompensated cirrhosis#445705IRIS
• Effect of an Integrated Exercise Training Program on Muscle Mass and Functional Capacity in Sarcopenic Patients With Decompensated Liver Cirrhosis.#446206NCBI PubMed Central
• The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy#807552ClinicalTrials.gov